Analytical Advances: Funneling a Flood Tide of Data — New Software Accelerates B

Fail more often and fail faster. Pharmaceutical companies are increasingly realizing that the key to a successful product pipeline is eliminating the inevitable unsuccessful products as quickly as possible. And in the pursuit of failure, the most powerful tool is information. The massive commercial databases that contain terabytes of information — including the entire human genome — ought to make it easier than ever to eliminate dead ends. But there’s just o­ne problem: Every year large pharmaceutical companies spend billions of dollars o­n R&D o­nly to scrap hundreds of products that don’t pan out. The “what if” results that can kill a drug before it reaches clinical trials often show up o­nly after years of development. Until recently, 15 years was not uncommon. So the sooner researchers can see the endgame in their data, the better.

For full article Click Here